Mary S McCabe
Affiliation: Memorial Sloan-Kettering Cancer Center
- Survivorship care: models and programsMary S McCabe
Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Semin Oncol Nurs 24:202-7. 2008..To review models of care for adult cancer survivors and the challenges in program development...
- Survivorship programs and care planningMary S McCabe
Cancer Survivorship Program, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
Cancer 119:2179-86. 2013..A review of research focused on the evaluation of definitions and outcomes is provided along with a discussion of important areas requiring future research...
- Clinical update: survivorship care--models and programsMary S McCabe
Cancer Survivorship Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
Semin Oncol Nurs 28:e1-8. 2012..To provide a clinical update of models of care for adult cancer survivors and the challenges in program development...
- Survivorship care plans: is there buy-in from community oncology providers?Talya Salz
Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York
Cancer 120:722-30. 2014..The Institute of Medicine recommended that survivors of cancer and their primary care providers receive survivorship care plans (SCPs) to summarize cancer treatment and plan ongoing care. However, the use of SCPs remains limited...
- Risk-based health care, the cancer survivor, the oncologist, and the primary care physicianMary S McCabe
Survivorship Program, Memorial Sloan Kettering Cancer Center, New York, NY
Semin Oncol 40:804-12. 2013....
- Models for delivering survivorship careKevin C Oeffinger
Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
J Clin Oncol 24:5117-24. 2006..The aims of this article are to provide a rationale for survivor health care and to articulate a taxonomy of models of survivor care that is applicable to both community practices and academic institutions...
- Looking beyond survival survivorship care is critical to the future of oncologyMary S McCabe
Cancer Survivorship Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA
Oncology (Williston Park) 21:398. 2007
- Survivorship care plans in research and practiceTalya Salz
Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
CA Cancer J Clin 62:101-17. 2012..SCPs are not widely used in NCI-designated cancer centers. Variation in practice is substantial, and many components recommended by the IOM framework are rarely included. \..
- Clinical ethics consultation in patients with head and neck cancerAndrew G Shuman
Head and Neck Surgery Service, Memorial Sloan Kettering Cancer Center, New York, New York Ethics Committee, Memorial Sloan Kettering Cancer Center, New York, New York Division of Medical Ethics, Weill Cornell Medical College, New York, New York
Head Neck 35:1647-51. 2013..The purpose of this study was to describe the impact of clinical ethics consultations among patients with head and neck cancer in order to better anticipate and manage clinical challenges...
- Melanoma survivorship: research opportunitiesSusan A Oliveria
Department of Medicine, Dermatology Service, Memorial Sloan Kettering Cancer Center, 160 East 53rd Street, New York, NY 10022, USA
J Cancer Surviv 1:87-97. 2007..Here, we outline the important research opportunities related to the study of melanoma survivorship and summarize the paucity of literature currently available...
- Living beyond cancer: survivorship is more than survivingMary S McCabe
Nat Clin Pract Urol 4:575. 2007
- Ethics guidelines for research with the recently deadRebecca D Pentz
Winship Cancer Institute, Emory University, 1365 C Clifton Road NE, C30008, Atlanta, Georgia 30322, USA
Nat Med 11:1145-9. 2005....
- Risks and benefits of phase 1 oncology trials, 1991 through 2002Elizabeth Horstmann
Department of Clinical Bioethics, Warren G Magnuson Clinical Center, National Institutes of Health, Bethesda, MD 20892 1156, USA
N Engl J Med 352:895-904. 2005..Previous reviews of phase 1 oncology trials reported a rate of response to treatment of 4 to 6 percent and a toxicity-related death rate of 0.5 percent. These results may not reflect the rates in current phase 1 oncology trials...
- Tissue collection for correlative studies in childhood cancer clinical trials: ethical considerations and special imperativesBarry D Anderson
National Cancer Institute, Cancer Therapy Evaluation Program, Rockville, MD 20892 7436, USA
J Clin Oncol 22:4846-50. 2004....
- Progress against cancer: the National Cancer Institute's roleMary S McCabe
National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA
J Cancer Educ 18:161-3. 2003
- Incremental treatment costs in national cancer institute-sponsored clinical trialsDana P Goldman
RAND Health, 1700 Main St, Santa Monica, CA 90407 2138, USA
JAMA 289:2970-7. 2003..Concern about additional costs for direct patient care impedes efforts to enroll patients in clinical trials. But generalizable evidence substantiating these concerns is lacking...